MedTrace Logo

Effects of Glucagon Administration on Energy Expenditure

NCT02237053 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-04-26

No results posted yet for this study

Summary

The purpose of this study is to collect data to help researchers better understand the effects of glucagon on the amount of calories burned.

Conditions

Interventions

DRUG

Glucagon

DRUG

Octreotide

BEHAVIORAL

Placebo

DRUG

Insulin

Sponsors & Collaborators

  • AdventHealth Translational Research Institute

    lead OTHER

Principal Investigators

  • Christian Meyer, MD · Translational Research Institute for Metabolism and Diabetes

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02237053 on ClinicalTrials.gov